ChEs/MAOs-IN-2, identified by its CAS number 693268-77-8, is a chemical compound that functions primarily as an inhibitor of certain enzymes, specifically cholinesterases (ChEs) and monoamine oxidases (MAOs). These enzymes play crucial roles in neurotransmitter regulation and metabolism, making this compound of interest in pharmacological research, particularly for conditions related to neurodegeneration and mood disorders. The compound is typically characterized by its specific molecular structure, which allows it to interact selectively with the target enzymes, potentially leading to increased levels of neurotransmitters such as acetylcholine and monoamines in the brain. Its efficacy and safety profile would be evaluated through various in vitro and in vivo studies, focusing on its potency, selectivity, and possible side effects. As with many enzyme inhibitors, the therapeutic applications may extend to treating diseases like Alzheimer's or depression, but further research is necessary to fully understand its biological effects and potential clinical uses.

ChEs/MAOs-IN-2

693268-77-8: ChEs/MAOs-IN-2, identified by its CAS number 693268-77-8, is a chemical compound that functions primarily as an inhibitor of certain enzymes, specifically cholinesterases (ChEs) and monoamine oxidases (MAOs). These enzymes play crucial roles in neurotransmitter regulation and metabolism, making this compound of interest in pharmacological research, particularly for conditions related to neurodegeneration and mood disorders. The compound is typically characterized by its specific molecular structure, which allows it to interact selectively with the target enzymes, potentially leading to increased levels of neurotransmitters such as acetylcholine and monoamines in the brain. Its efficacy and safety profile would be evaluated through various in vitro and in vivo studies, focusing on its potency, selectivity, and possible side effects. As with many enzyme inhibitors, the therapeutic applications may extend to treating diseases like Alzheimer's or depression, but further research is necessary to fully understand its biological effects and potential clinical uses.

ChEs/MAOs-IN-2 (compound a11) serves as an inhibitor for both cholinesterases and monoamine oxidases, exhibiting IC 50 values of 0.10 µM for MAO-A, 0.20 µM for MAO-B, 0.30 µM for AChE, and 0.40 µM for BChE. This compound shows promise for Alzheimer's disease research [1].

CAS 693268-77-8

ChEs/MAOs-IN-2

ChEs/MAOs-IN-2

Ref: TM-T86047